Difference between revisions of "Team:SDU-Denmark/Parts"
| Line 22: | Line 22: | ||
<p><a href="http://parts.igem.org/Part:BBa_K2018006" target="blank"><strong>BBa_K2018006</strong></a></p> | <p><a href="http://parts.igem.org/Part:BBa_K2018006" target="blank"><strong>BBa_K2018006</strong></a></p> | ||
| − | <p><span style="font-weight: 400;">This BioBrick contain the coding region of </span><strong>Lacticin Q</strong><span style="font-weight: 400;">, a bacteriocin </span><span style="font-weight: 400;"> produced by </span><em><span style="font-weight: 400;">Lactococcus lactis QU5 </span></em><span style="font-weight: 400;"> and has shown bactericidal activity against </span><em><span style="font-weight: 400;">Staphylococcus aureus </span></em><span style="font-weight: 400;">[</span><a href="http://www.ncbi.nlm.nih.gov/pubmed/22538663"><span style="font-weight: 400;">http://www.ncbi.nlm.nih.gov/pubmed/22538663</span></a><span style="font-weight: 400;"> ]. It function by forming large toroidal pores by distributing membrane lipid organization.</span></p> | + | <p><span style="font-weight: 400;">This BioBrick contain the coding region of </span><strong>Lacticin Q</strong><span style="font-weight: 400;">, a bacteriocin </span><span style="font-weight: 400;"> produced by </span><em><span style="font-weight: 400;">Lactococcus lactis QU5 </span></em><span style="font-weight: 400;"> and has shown bactericidal activity against </span><em><span style="font-weight: 400;">Staphylococcus aureus </span></em><span style="font-weight: 400;">[</span><a href="http://www.ncbi.nlm.nih.gov/pubmed/22538663" target="blank"><span style="font-weight: 400;">http://www.ncbi.nlm.nih.gov/pubmed/22538663</span></a><span style="font-weight: 400;">]. It function by forming large toroidal pores by distributing membrane lipid organization.</span></p> |
<p><a href="http://parts.igem.org/Part:BBa_K2018008" target="blank"><strong>BBa_K2018008</strong></a></p> | <p><a href="http://parts.igem.org/Part:BBa_K2018008" target="blank"><strong>BBa_K2018008</strong></a></p> | ||
| Line 31: | Line 31: | ||
<p><a href="http://parts.igem.org/Part:BBa_K2018018" target="blank"><strong>BBa_K2018018</strong></a></p> | <p><a href="http://parts.igem.org/Part:BBa_K2018018" target="blank"><strong>BBa_K2018018</strong></a></p> | ||
| − | <p><span style="font-weight: 400;">This BioBrick contain the coding region of </span><strong>Pyocin S5, </strong><span style="font-weight: 400;">a bacteriocin</span> <span style="font-weight: 400;">produced by a specific strain of </span><em><span style="font-weight: 400;">P. aeruginosa </span></em><span style="font-weight: 400;">and elicit its effect against other strains of </span><em><span style="font-weight: 400;">P. aeruginosa</span></em><span style="font-weight: 400;">. Pyocin causes the cell membrane of target cells to be permeable and thereby causing leakage of intracellular materials, which cause cell death [</span><a href="http://www.sciencedirect.com/science/article/pii/S0014579310005120"><span style="font-weight: 400;">http://www.sciencedirect.com/science/article/pii/S0014579310005120</span></a><span style="font-weight: 400;">].</span></p> | + | <p><span style="font-weight: 400;">This BioBrick contain the coding region of </span><strong>Pyocin S5, </strong><span style="font-weight: 400;">a bacteriocin</span> <span style="font-weight: 400;">produced by a specific strain of </span><em><span style="font-weight: 400;">P. aeruginosa </span></em><span style="font-weight: 400;">and elicit its effect against other strains of </span><em><span style="font-weight: 400;">P. aeruginosa</span></em><span style="font-weight: 400;">. Pyocin causes the cell membrane of target cells to be permeable and thereby causing leakage of intracellular materials, which cause cell death [</span><a href="http://www.sciencedirect.com/science/article/pii/S0014579310005120" target="blank"><span style="font-weight: 400;">http://www.sciencedirect.com/science/article/pii/S0014579310005120</span></a><span style="font-weight: 400;">].</span></p> |
Revision as of 07:02, 12 October 2016
Parts
Basic
This BioBrick contain the coding region of Laterosporulin, a bacteriocin produced by Brevibacillus sp. strain, and exhibit a broad spectrum of antibacterial activity against bacterias like: B. subtilis , S. aureus, E. coli, P. aeruginosa, and L. monocytogenes.
This BioBrick contain the coding region of, Thuricin S, a bacteriocin produced by Bacillus thuringiensis. Thuricin S target a broad spectrum of pathogens, including Pseudonoas aeruginosa and Enterobactoer Cloacae which is often found in correlation to burn and wound infection.
This BioBrick contain the coding region of Lacticin Q, a bacteriocin produced by Lactococcus lactis QU5 and has shown bactericidal activity against Staphylococcus aureus [http://www.ncbi.nlm.nih.gov/pubmed/22538663]. It function by forming large toroidal pores by distributing membrane lipid organization.
This BioBrick contain the coding region of Laterosporulin-Thuricin S, which is a hybrid bacteriocin with Laterosporulin and Thuricin S we had designed.
This BioBrick contain the coding region of Lacticin Q-Lacticin Z, which is a hybrid bacteriocin with Lacticin Q and Lacticin Z we had designed.
This BioBrick contain the coding region of Pyocin S5, a bacteriocin produced by a specific strain of P. aeruginosa and elicit its effect against other strains of P. aeruginosa. Pyocin causes the cell membrane of target cells to be permeable and thereby causing leakage of intracellular materials, which cause cell death [http://www.sciencedirect.com/science/article/pii/S0014579310005120].
